Selected research
Industry Research
Pediatric Drugs Industry Research Report 2026
Market perspective
The global Pediatric Drugs market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Pediatric Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Pediatric Drugs is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Pediatric Drugs is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Pediatric Drugs include Abbott Laboratories, Boehringer Ingelheim, Bristol-Myers Squibb, Colgate Oral Pharmaceuticals, Forest Laboratories, Genentech, MedImmune, Novo Nordisk and Pharmacia, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Pediatric Drugs market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Pediatric Drugs Market by Company
Abbott Laboratories
Boehringer Ingelheim
Bristol-Myers Squibb
Colgate Oral Pharmaceuticals
Forest Laboratories
Genentech
MedImmune
Novo Nordisk
Pharmacia
Schering-Plough
Bayer
GlaxoSmithKline
Pfizer
Eli Lilly
Roche
Merck
Novartis Pharmaceuticals
Johnson & Johnson
Pediatric Drugs Segment by Type
Cancer Therapies
Allergy and Respiratory Drugs
Hormone Drugs
Anti-Infectives
Urological Drugs
Gastrointestinal Drugs
Cardiovascular Drugs
Central Nervous System Drugs
Pediatric Drugs Segment by Application
Hospital
Clinic
Drugstore
Pediatric Drugs Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pediatric Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pediatric Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pediatric Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Pediatric Drugs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Pediatric Drugs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Pediatric Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Cancer Therapies
- Allergy and Respiratory Drugs
- Hormone Drugs
- Anti-Infectives
- Urological Drugs
- Gastrointestinal Drugs
- Cardiovascular Drugs
- Central Nervous System Drugs
Applications
- Hospital
- Clinic
- Drugstore
Companies covered
- Abbott Laboratories
- Boehringer Ingelheim
- Bristol-Myers Squibb
- Colgate Oral Pharmaceuticals
- Forest Laboratories
- Genentech
- MedImmune
- Novo Nordisk
- Pharmacia
- Schering-Plough
- Bayer
- GlaxoSmithKline
- Pfizer
- Eli Lilly
- Roche
- Merck
- Novartis Pharmaceuticals
- Johnson & Johnson
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Pediatric Drugs Market Size (2021-2032)
- 2.2.2 Global Pediatric Drugs Sales (2021-2032)
- 2.2.3 Global Pediatric Drugs Market Average Price (2021-2032)
- 2.3 Pediatric Drugs by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Cancer Therapies
- 2.3.3 Allergy and Respiratory Drugs
- 2.3.4 Hormone Drugs
- 2.3.5 Anti-Infectives
- 2.3.6 Urological Drugs
- 2.3.7 Gastrointestinal Drugs
- 2.3.8 Cardiovascular Drugs
- 2.3.9 Central Nervous System Drugs
- 2.4 Pediatric Drugs by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Clinic
- 2.4.4 Drugstore
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Pediatric Drugs Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Pediatric Drugs Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Pediatric Drugs Revenue of Manufacturers (2021-2026)
- 3.4 Global Pediatric Drugs Average Price by Manufacturers (2021-2026)
- 3.5 Global Pediatric Drugs Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Pediatric Drugs, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Pediatric Drugs, Product Type & Application
- 3.8 Global Manufacturers of Pediatric Drugs, Established Date
- 3.9 Global Pediatric Drugs Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Abbott Laboratories
- 4.1.1 Abbott Laboratories Company Information
- 4.1.2 Abbott Laboratories Business Overview
- 4.1.3 Abbott Laboratories Pediatric Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Abbott Laboratories Pediatric Drugs Product Portfolio
- 4.1.5 Abbott Laboratories Recent Developments
- 4.2 Boehringer Ingelheim
- 4.2.1 Boehringer Ingelheim Company Information
- 4.2.2 Boehringer Ingelheim Business Overview
- 4.2.3 Boehringer Ingelheim Pediatric Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Boehringer Ingelheim Pediatric Drugs Product Portfolio
- 4.2.5 Boehringer Ingelheim Recent Developments
- 4.3 Bristol-Myers Squibb
- 4.3.1 Bristol-Myers Squibb Company Information
- 4.3.2 Bristol-Myers Squibb Business Overview
- 4.3.3 Bristol-Myers Squibb Pediatric Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Bristol-Myers Squibb Pediatric Drugs Product Portfolio
- 4.3.5 Bristol-Myers Squibb Recent Developments
- 4.4 Colgate Oral Pharmaceuticals
- 4.4.1 Colgate Oral Pharmaceuticals Company Information
- 4.4.2 Colgate Oral Pharmaceuticals Business Overview
- 4.4.3 Colgate Oral Pharmaceuticals Pediatric Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Colgate Oral Pharmaceuticals Pediatric Drugs Product Portfolio
- 4.4.5 Colgate Oral Pharmaceuticals Recent Developments
- 4.5 Forest Laboratories
- 4.5.1 Forest Laboratories Company Information
- 4.5.2 Forest Laboratories Business Overview
- 4.5.3 Forest Laboratories Pediatric Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Forest Laboratories Pediatric Drugs Product Portfolio
- 4.5.5 Forest Laboratories Recent Developments
- 4.6 Genentech
- 4.6.1 Genentech Company Information
- 4.6.2 Genentech Business Overview
- 4.6.3 Genentech Pediatric Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Genentech Pediatric Drugs Product Portfolio
- 4.6.5 Genentech Recent Developments
- 4.7 MedImmune
- 4.7.1 MedImmune Company Information
- 4.7.2 MedImmune Business Overview
- 4.7.3 MedImmune Pediatric Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 MedImmune Pediatric Drugs Product Portfolio
- 4.7.5 MedImmune Recent Developments
- 4.8 Novo Nordisk
- 4.8.1 Novo Nordisk Company Information
- 4.8.2 Novo Nordisk Business Overview
- 4.8.3 Novo Nordisk Pediatric Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Novo Nordisk Pediatric Drugs Product Portfolio
- 4.8.5 Novo Nordisk Recent Developments
- 4.9 Pharmacia
- 4.9.1 Pharmacia Company Information
- 4.9.2 Pharmacia Business Overview
- 4.9.3 Pharmacia Pediatric Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Pharmacia Pediatric Drugs Product Portfolio
- 4.9.5 Pharmacia Recent Developments
- 4.10 Schering-Plough
- 4.10.1 Schering-Plough Company Information
- 4.10.2 Schering-Plough Business Overview
- 4.10.3 Schering-Plough Pediatric Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Schering-Plough Pediatric Drugs Product Portfolio
- 4.10.5 Schering-Plough Recent Developments
- 4.11 Bayer
- 4.11.1 Bayer Company Information
- 4.11.2 Bayer Business Overview
- 4.11.3 Bayer Pediatric Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Bayer Pediatric Drugs Product Portfolio
- 4.11.5 Bayer Recent Developments
- 4.12 GlaxoSmithKline
- 4.12.1 GlaxoSmithKline Company Information
- 4.12.2 GlaxoSmithKline Business Overview
- 4.12.3 GlaxoSmithKline Pediatric Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 GlaxoSmithKline Pediatric Drugs Product Portfolio
- 4.12.5 GlaxoSmithKline Recent Developments
- 4.13 Pfizer
- 4.13.1 Pfizer Company Information
- 4.13.2 Pfizer Business Overview
- 4.13.3 Pfizer Pediatric Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Pfizer Pediatric Drugs Product Portfolio
- 4.13.5 Pfizer Recent Developments
- 4.14 Eli Lilly
- 4.14.1 Eli Lilly Company Information
- 4.14.2 Eli Lilly Business Overview
- 4.14.3 Eli Lilly Pediatric Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Eli Lilly Pediatric Drugs Product Portfolio
- 4.14.5 Eli Lilly Recent Developments
- 4.15 Roche
- 4.15.1 Roche Company Information
- 4.15.2 Roche Business Overview
- 4.15.3 Roche Pediatric Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Roche Pediatric Drugs Product Portfolio
- 4.15.5 Roche Recent Developments
- 4.16 Merck
- 4.16.1 Merck Company Information
- 4.16.2 Merck Business Overview
- 4.16.3 Merck Pediatric Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Merck Pediatric Drugs Product Portfolio
- 4.16.5 Merck Recent Developments
- 4.17 Novartis Pharmaceuticals
- 4.17.1 Novartis Pharmaceuticals Company Information
- 4.17.2 Novartis Pharmaceuticals Business Overview
- 4.17.3 Novartis Pharmaceuticals Pediatric Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 Novartis Pharmaceuticals Pediatric Drugs Product Portfolio
- 4.17.5 Novartis Pharmaceuticals Recent Developments
- 4.18 Johnson & Johnson
- 4.18.1 Johnson & Johnson Company Information
- 4.18.2 Johnson & Johnson Business Overview
- 4.18.3 Johnson & Johnson Pediatric Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.18.4 Johnson & Johnson Pediatric Drugs Product Portfolio
- 4.18.5 Johnson & Johnson Recent Developments
5 Global Pediatric Drugs Market Scenario by Region
- 5.1 Global Pediatric Drugs Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Pediatric Drugs Sales by Region: 2021-2032
- 5.2.1 Global Pediatric Drugs Sales by Region: 2021-2026
- 5.2.2 Global Pediatric Drugs Sales by Region: 2027-2032
- 5.3 Global Pediatric Drugs Revenue by Region: 2021-2032
- 5.3.1 Global Pediatric Drugs Revenue by Region: 2021-2026
- 5.3.2 Global Pediatric Drugs Revenue by Region: 2027-2032
- 5.4 North America Pediatric Drugs Market Facts & Figures by Country
- 5.4.1 North America Pediatric Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Pediatric Drugs Sales by Country (2021-2032)
- 5.4.3 North America Pediatric Drugs Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Pediatric Drugs Market Facts & Figures by Country
- 5.5.1 Europe Pediatric Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Pediatric Drugs Sales by Country (2021-2032)
- 5.5.3 Europe Pediatric Drugs Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.5.9 Nordic Countries
- 5.6 Asia Pacific Pediatric Drugs Market Facts & Figures by Country
- 5.6.1 Asia Pacific Pediatric Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Pediatric Drugs Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Pediatric Drugs Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Pediatric Drugs Market Facts & Figures by Country
- 5.7.1 South America Pediatric Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Pediatric Drugs Sales by Country (2021-2032)
- 5.7.3 South America Pediatric Drugs Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Pediatric Drugs Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Pediatric Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Pediatric Drugs Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Pediatric Drugs Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Pediatric Drugs Sales by Type (2021-2032)
- 6.1.1 Global Pediatric Drugs Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Pediatric Drugs Sales Market Share by Type (2021-2032)
- 6.2 Global Pediatric Drugs Revenue by Type (2021-2032)
- 6.2.1 Global Pediatric Drugs Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Pediatric Drugs Revenue Market Share by Type (2021-2032)
- 6.3 Global Pediatric Drugs Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Pediatric Drugs Sales by Application (2021-2032)
- 7.1.1 Global Pediatric Drugs Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Pediatric Drugs Sales Market Share by Application (2021-2032)
- 7.2 Global Pediatric Drugs Revenue by Application (2021-2032)
- 7.2.1 Global Pediatric Drugs Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Pediatric Drugs Revenue Market Share by Application (2021-2032)
- 7.3 Global Pediatric Drugs Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Pediatric Drugs Value Chain Analysis
- 8.1.1 Pediatric Drugs Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Pediatric Drugs Production Mode & Process
- 8.2 Pediatric Drugs Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Pediatric Drugs Distributors
- 8.2.3 Pediatric Drugs Customers
9 Global Pediatric Drugs Analyzing Market Dynamics
- 9.1 Pediatric Drugs Industry Trends
- 9.2 Pediatric Drugs Industry Drivers
- 9.3 Pediatric Drugs Industry Opportunities and Challenges
- 9.4 Pediatric Drugs Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst